Updated:
Humain
Humain create digital humans for world leading entertainment and technology companies. | Humain create digital humans for world leading entertainment and...
Overview
Humain create digital humans for world leading entertainment and technology companies. | Humain create digital humans for world leading entertainment and technology companies by combining a deep understanding of production with disruptive technologies.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
Multiple offices
Corporate office
New York, Palo Alto, San Francisco, Saratoga, Belfast, Sugar Land, Rahway, Menlo Park, Oakland, Miami Beach, United States
Additional offices
Palo Alto · San Francisco · Saratoga · Belfast · Sugar Land · Rahway · Menlo Park · Oakland · Miami Beach
Sector focus
Frequently asked questions
What does Humain invest in?
Humain invests in early-stage companies at the intersection of artificial intelligence and human health. Its mandate spans AI-enabled drug discovery, continuous biosensing, novel therapeutics, and prevention-first care delivery models. These technical bets distinguish the firm from generalist digital health or software investors.
How is Humain different from a broad digital health fund?
Humain is not a general digital health investor. Its explicit thesis at the convergence of AI, therapeutics, and biosensing requires scientific fluency in computational biology, medical device R&D, and health system infrastructure — a narrower, deeper technical capability set than most healthcare venture capital firms maintain. This thesis reliance creates both a sourcing edge and concentration risk.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: